4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-025560
EVP, Chief Legal Officer sold 8,389 shares at an average $2.04 ($17,089)
From the SEC's structured data for this filing
Trades in this filing
Murugan Amar · EVP, Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-16 | Sale : show line 1 in the form | −7,404 | $2.04 | $15,082 | 271,930 | D |
| 2023-05-16 | Sale : show line 2 in the form | −985 | $2.04 | $2,007 | 270,945 | D |
| Open-market sales · 8,389 sh · avg $2.04 · $17,089 | ||||||
Loading xslF345X04/form4.xml…